27th Apr 2011 17:59
GW Pharmaceuticals plc
Notification of Results
Porton Down, UK, 27 April 2011: GW Pharmaceuticals plc (AIM: GWP) will be announcing its interim financial results for the six months ended 31 March 2010 on Tuesday 17 May 2011.
Enquiries:
Financial Dynamics | 020 7831 3113 |
Ben Atwell / John Dineen |
Notes to Editors
About GW
GW was founded in 1998 and listed on the AIM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious ailments, in particular multiple sclerosis and cancer pain. GW has assembled a large in-house scientific team with expertise in cannabinoid science as well as experience in the development of both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field. For further information, please visit www.gwpharm.com
Related Shares:
GWP.L